TY - JOUR
T1 - Glyoxal and methylglyoxal trigger distinct signals for MAP family kinases and caspase activation in human endothelial cells
AU - Akhand, Anwarul A.
AU - Hossain, Khaled
AU - Mitsui, Hiroko
AU - Kato, Masashi
AU - Miyata, Toshio
AU - Inagi, Reiko
AU - Du, Jun
AU - Takeda, Kozue
AU - Kawamoto, Yoshiyuki
AU - Suzuki, Haruhiko
AU - Kurokawa, Kiyoshi
AU - Nakashima, Izumi
N1 - Funding Information:
This work was supported in part by the funds for comprehensive research on aging and health from the Ministry of Health and Welfare of Japan and by Grants-in-aid for Scientific Research of priority Areas and Center of Excellence (COE) Research from the Ministry of Education, Science, Sports, and Culture of Japan. We thank Y. Umeda and H. Saeki for technical assistance.
PY - 2001/7/1
Y1 - 2001/7/1
N2 - Carbonyl compounds with diverse carbon skeletons may be differentially related to the pathogenesis of vascular diseases. In this study, we compared intracellular signals delivered into cultured human umbilical vein endothelial cells (HUVECs) by glyoxal (GO) and methylglyoxal (MGO), which differ only by a methyl group. Depending on their concentrations, GO and MGO promoted phosphorylations of ERK1 and ERK2, which were blocked by the protein-tyrosine kinase (PTK) inhibitors herbimycin A and staurosporine, thereby being PTK-dependent. GO and MGO also induced phosphorylations of JNK, p38 MAPK, and c-Jun, either PTK-dependently (GO) or -independently (MGO). Next, we found that MGO, but not GO, induced degradation of poly(ADP-ribose) polymerase (PARP) as the intracellular substrate of caspase-3. Curcumin and SB203580, which inhibit JNK and p38 MAPK signaling pathways, but not herbimycin A/staurosporine, prevented the MGO-induced PARP degradation. We then found that MGO, but not GO, reduced the intracellular glutathione level, and that cysteine, but not cystine, inhibited the MGO-mediated activation of ERK, JNK, p38 MAPK, or c-Jun more extensively than did lysine or arginine. In addition, all the signals triggered by GO and MGO were blocked by amino guanidine (AG), which traps carbonyls. These results demonstrated that GO and MGO triggered two distinct signal cascades, one for PTK-dependent control of ERK and another for PTK-independent redox-linked activation of JNK/p38 MAPK and caspases in HUVECs, depending on the structure of the carbon skeleton of the chemicals.
AB - Carbonyl compounds with diverse carbon skeletons may be differentially related to the pathogenesis of vascular diseases. In this study, we compared intracellular signals delivered into cultured human umbilical vein endothelial cells (HUVECs) by glyoxal (GO) and methylglyoxal (MGO), which differ only by a methyl group. Depending on their concentrations, GO and MGO promoted phosphorylations of ERK1 and ERK2, which were blocked by the protein-tyrosine kinase (PTK) inhibitors herbimycin A and staurosporine, thereby being PTK-dependent. GO and MGO also induced phosphorylations of JNK, p38 MAPK, and c-Jun, either PTK-dependently (GO) or -independently (MGO). Next, we found that MGO, but not GO, induced degradation of poly(ADP-ribose) polymerase (PARP) as the intracellular substrate of caspase-3. Curcumin and SB203580, which inhibit JNK and p38 MAPK signaling pathways, but not herbimycin A/staurosporine, prevented the MGO-induced PARP degradation. We then found that MGO, but not GO, reduced the intracellular glutathione level, and that cysteine, but not cystine, inhibited the MGO-mediated activation of ERK, JNK, p38 MAPK, or c-Jun more extensively than did lysine or arginine. In addition, all the signals triggered by GO and MGO were blocked by amino guanidine (AG), which traps carbonyls. These results demonstrated that GO and MGO triggered two distinct signal cascades, one for PTK-dependent control of ERK and another for PTK-independent redox-linked activation of JNK/p38 MAPK and caspases in HUVECs, depending on the structure of the carbon skeleton of the chemicals.
KW - Caspase-3
KW - Free radicals
KW - Glyoxal
KW - HUVEC
KW - MAP family kinase
KW - Methylglyoxal
UR - http://www.scopus.com/inward/record.url?scp=0035399660&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035399660&partnerID=8YFLogxK
U2 - 10.1016/S0891-5849(01)00550-0
DO - 10.1016/S0891-5849(01)00550-0
M3 - Article
C2 - 11425486
AN - SCOPUS:0035399660
SN - 0891-5849
VL - 31
SP - 20
EP - 30
JO - Free Radical Biology and Medicine
JF - Free Radical Biology and Medicine
IS - 1
ER -